Stapled peptide-based membrane fusion inhibitors of hepatitis C virus

被引：61
|
作者：
Cui, Hong-Kui [1 ]
Qing, Jie [1 ]
Guo, Ye [1 ]
Wang, Yu-Jia [1 ]
Cui, Li-Jia [2 ,3 ]
He, Tian-Hua [2 ,3 ]
Zhang, Linqi [2 ,3 ]
Liu, Lei [1 ]
机构：
[1] Tsinghua Univ, Dept Chem, Tsinghua Peking Ctr Life Sci,Minist Educ, Key Lab Bioorgan Phosphorus Chem & Chem Biol, Beijing 100084, Peoples R China
[2] Tsinghua Univ, Sch Med, Comprehens AIDS Res Ctr, Beijing 100084, Peoples R China
[3] Tsinghua Univ, Sch Med, Res Ctr Publ Hlth, Beijing 100084, Peoples R China
来源：
BIOORGANIC & MEDICINAL CHEMISTRY | 2013年 / 21卷 / 12期
基金：
中国国家自然科学基金;
关键词：
Hepatitis C virus; Stapled peptide; Protein-protein interaction; CELL-CULTURE SYSTEMS; B TYPE-I; OLEFIN METATHESIS; ALPHA-HELICES; BH3; HELIX; CD81; ENTRY; INFECTION; PROTEINS; RECEPTOR;
D O I：
10.1016/j.bmc.2013.02.011
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
The strategy of peptide stapling was used to develop new molecules to inhibit the hepatitis C virus infection via disrupting the binding of HCV envelope glycoprotein E2 with human cell surface protein CD81. The peptide sequence was designed based on the large extra-cellular loop of CD81 with known importance in the HCV E2 binding interaction. Our results showed that the stapled peptides exhibited significantly higher alpha-helicity and proteolytic stability as compared to their linear peptide counterpart. The optimal compound was found to have an EC50 value of ca. 17-39 mu M against different HCV subtypes and represented a new HCV membrane fusion inhibitor. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码：3547 / 3554
页数：8
相关论文
共 50 条
  • [41] Inhibitors Targeting Hepatitis C Virus (HCV) Entry
    Santos Junior, Paulo Fernando da Silva
    de Araujo Junior, Joao Xavier
    da Silva Junior, Edeildo Ferreira
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2023, 23 (11) : 1193 - 1221
  • [42] Antimicrobial peptide LL-37 attenuates infection of hepatitis C virus
    Matsumura, Takuya
    Sugiyama, Nao
    Murayama, Asako
    Yamada, Norie
    Shiina, Masaaki
    Asabe, Shinichi
    Wakita, Takaji
    Imawari, Michio
    Kato, Takanobu
    HEPATOLOGY RESEARCH, 2016, 46 (09) : 924 - 932
  • [43] Substituted benzothiadizine inhibitors of Hepatitis C virus polymerase
    Shaw, Antony N.
    Tedesco, Rosanna
    Bambal, Ramesh
    Chai, Deping
    Concha, Nestor O.
    Darcy, Michael G.
    Dhanak, Dashyant
    Duffy, Kevin J.
    Fitch, Duke M.
    Gates, Adam
    Johnston, Victor K.
    Keenan, Richard M.
    Lin-Goerke, Juili
    Liu, Nannan
    Sarisky, Robert T.
    Wiggall, Kenneth J.
    Zimmerman, Michael N.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (15) : 4350 - 4353
  • [44] Entry Inhibitors: A Perspective for Prevention of Hepatitis C Virus Infection in Organ Transplantation
    Colpitts, Che C.
    Chung, Raymond T.
    Baumert, Thomas F.
    ACS INFECTIOUS DISEASES, 2017, 3 (09): : 620 - 623
  • [45] Chlorcyclizine Inhibits Viral Fusion of Hepatitis C Virus Entry by Directly Targeting HCV Envelope Glycoprotein 1
    Hu, Zongyi
    Rolt, Adam
    Hu, Xin
    Ma, Christopher D.
    Le, Derek J.
    Park, Seung Bum
    Houghton, Michael
    Southall, Noel
    Anderson, D. Eric
    Talley, Daniel C.
    Lloyd, John R.
    Marugan, Juan C.
    Liang, T. Jake
    CELL CHEMICAL BIOLOGY, 2020, 27 (07): : 780 - +
  • [46] Identification of Hepatitis C Virus Inhibitors Targeting Different Aspects of Infection Using a Cell-Based Assay
    Yu, Xuemei
    Sainz, Bruno, Jr.
    Petukhov, Pavel A.
    Uprichard, Susan L.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (12) : 6109 - 6120
  • [47] Peptide-based targeting of fluorescent zinc sensors to the plasma membrane of live cells
    Radford, Robert J.
    Chyan, Wen
    Lippard, Stephen J.
    CHEMICAL SCIENCE, 2013, 4 (08) : 3080 - 3084
  • [48] Epoxide based inhibitors of the hepatitis C virus non-structural 2 autoprotease
    Shaw, Joseph
    Fishwick, Colin W. G.
    Harris, Mark
    ANTIVIRAL RESEARCH, 2015, 117 : 20 - 26
  • [49] Structural Basis of HIV-1 gp41 N-trimer for Designing Bifunctional Peptide-based Fusion Inhibitors
    Wang, Jinlin
    Li, Peiying
    Li, Ruijuan
    Liang, Guodong
    Ma, Yuheng
    Na, Heiya
    CURRENT MEDICINAL CHEMISTRY, 2024,
  • [50] A fusion peptide in preS1 and the human protein disulfide isomerase ERp57 are involved in hepatitis B virus membrane fusion process
    Perez-Vargas, Jimena
    Teppa, Elin
    Amirache, Fouzia
    Boson, Bertrand
    de Oliveira, Remi Pereira
    Combet, Christophe
    Bockmann, Anja
    Fusil, Floriane
    Freitas, Natalia
    Carbone, Alessandra
    Cosset, Francois-Loic
    ELIFE, 2021, 10
12345